The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Idiopathic Pulmonary Alveolar Proteinosis as an Autoimmune Disease with Neutralizing Antibody against Granulocyte/Macrophage Colony-Stimulating Factor
Open accessAbstract
Idiopathic pulmonary alveolar proteinosis (I-PAP) is a rare disease of unknown etiology in which the alveoli fill with lipoproteinaceous material. We report here that I-PAP is an autoimmune disease with neutralizing antibody of immunoglobulin G isotype against granulocyte/macrophage colony-stimulating factor (GM-CSF). The antibody was found to be present in all specimens of bronchoalveolar lavage fluid obtained from 11 I-PAP patients but not in samples from 2 secondary PAP patients, 53 normal subjects, and 14 patients with other lung diseases. It specifically bound GM-CSF and neutralized bioactivity of the cytokine in vitro. The antibody was also found in sera from all I-PAP patients examined but not in sera from a secondary PAP patient or normal subjects, indicating that it exists systemically in I-PAP patients. As lack of GM-CSF signaling causes PAP in congenital cases and PAP-like disease in murine models, our findings strongly suggest that neutralization of GM-CSF bioactivity by the antibody causes dysfunction of alveolar macrophages, which results in reduced surfactant clearance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Involvement of Granulocyte-Macrophage Colony-Stimulating Factor in Pulmonary Homeostasis
Dranoff, G., Crawford, A. D., Sadelain, M., Ream, B., Rashid, A., Bronson, R. T., Dickersin, G. R., Bachurski, C. J., Mark, E. L., Whitsett, J. A., et al. (1994) · Science · doi:10.1126/science.8171324 · Cited by 879
Kitamura, T., Tange, T., Terasawa, T., Chiba, S., Kuwaki, T., Miyagawa, K., Piao, Y., Miyazono, K., Urabe, A., & Takaku, F. (1989) · Journal of Cellular Physiology · doi:10.1002/jcp.1041400219 · Cited by 784
Self-citationThe pulmonary surfactant system: biochemical aspects and functional significance
Van Golde, L. M., Batenburg, J. J., & Robertson, B. (1988) · Physiological Reviews · doi:10.1152/physrev.1988.68.2.374 · Cited by 333
Nishinakamura, R., Nakayama, N., Hirabayashi, Y., Inoue, T., Aud, D., Mcneil, T., Azuma, S., Yoshida, S., Toyoda, Y., Aral, K.-I., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90046-2 · Cited by 309
Huffman, J. A., Hull, W. M., Dranoff, G., Mulligan, R. C., & Whitsett, J. A. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118461 · Cited by 262
Pulmonary Alveolar Phospholipoproteinosis: Experience With 34 Cases and a Review
Prakash, U. B. S., Barham, S. S., Carpenter, H. A., Dines, D. E., & Marsh, H. W. (1987) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)65477-9 · Cited by 244
Dirksen, U., Nishinakamura, R., Groneck, P., Hattenhorst, U., Nogee, L., Murray, R., & Burdach, S. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119758 · Cited by 216
Defective Lung Macrophages in Pulmonary Alveolar Proteinosis
Golde, D. W., TERRITO, M., FINLEY, T. N., et al. (1976) · Annals of Internal Medicine · doi:10.7326/0003-4819-85-3-304 · Cited by 183
Pulmonary Alveolar Proteinosis
Goldstein, L. S., Kavuru, M. S., Curtis-McCarthy, P., Christie, H. A., Farver, C. F., & Stoller, J. K. (1998) · CHEST Journal · doi:10.1378/chest.114.5.1357 · Cited by 155
Cited by
Pulmonary Alveolar Proteinosis
Trapnell, B. C., Whitsett, J. A., & Nakata, K. (2003) · New England Journal of Medicine · doi:10.1056/nejmra023226 · Cited by 790
Self-citationPuel, A., Döffinger, R., Natividad, A., Chrabieh, M., Barcenas-Morales, G., Picard, C., Cobat, A., Ouachée-Chardin, M., Toulon, A., Bustamante, J., et al. (2010) · Journal of Experimental Medicine · doi:10.1084/jem.20091983 · Cited by 733
Pulmonary Alveolar Proteinosis: Progress in the First 44 Years
Seymour, J. F., & Presneill, J. J. (2002) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.2109105 · Cited by 697
Macrophages in health and disease
Park, M. D., Silvin, A., Ginhoux, F., & Merad, M. (2022) · Cell · doi:10.1016/j.cell.2022.10.007 · Cited by 644
Hydrophobic Surfactant Proteins in Lung Function and Disease
Whitsett, J. A., & Weaver, T. E. (2002) · New England Journal of Medicine · doi:10.1056/nejmra022387 · Cited by 519
Inoue, Y., Trapnell, B. C., Tazawa, R., Arai, T., Takada, T., Hizawa, N., Kasahara, Y., Tatsumi, K., Hojo, M., Ichiwata, T., et al. (2008) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200708-1271oc · Cited by 490
Self-citationMacrophages and lipid metabolism
Remmerie, A., & Scott, C. L. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.01.020 · Cited by 433
Pulmonary alveolar proteinosis
Trapnell, B. C., Nakata, K., Bonella, F., Campo, I., Griese, M., Hamilton, J., Wang, T., Morgan, C., Cottin, V., & McCarthy, C. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0066-3 · Cited by 397
Self-citationTrapnell, B. C., & Whitsett, J. A. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.090601.113847 · Cited by 352
Martin, T. R., & Frevert, C. W. (2005) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200508-090js · Cited by 341
Schneider, C., Nobs, S. P., Heer, A. K., Kurrer, M., Klinke, G., van Rooijen, N., Vogel, J., & Kopf, M. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004053 · Cited by 334
Vinh, D. C., Patel, S. Y., Uzel, G., Anderson, V. L., Freeman, A. F., Olivier, K. N., Spalding, C., Hughes, S., Pittaluga, S., Raffeld, M., et al. (2010) · Blood · doi:10.1182/blood-2009-03-208629 · Cited by 330
GM-CSF Autoantibodies and Neutrophil Dysfunction in Pulmonary Alveolar Proteinosis
Uchida, K., Beck, D. C., Yamamoto, T., Berclaz, P.-Y., Abe, S., Staudt, M. K., Carey, B. C., Filippi, M.-D., Wert, S. E., Denson, L. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa062505 · Cited by 317
Pulmonary macrophage transplantation therapy
Suzuki, T., Arumugam, P., Sakagami, T., Lachmann, N., Chalk, C., Sallese, A., Abe, S., Trapnell, C., Carey, B., Moritz, T., et al. (2014) · Nature · doi:10.1038/nature13807 · Cited by 307
Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA
Suzuki, T., Sakagami, T., Rubin, B. K., Nogee, L. M., Wood, R. E., Zimmerman, S. L., Smolarek, T., Dishop, M. K., Wert, S. E., Whitsett, J. A., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20080990 · Cited by 305
Pulmonary alveolar proteinosis
Borie, R., Danel, C., Debray, M.-P., Taille, C., Dombret, M.-C., Aubier, M., Epaud, R., & Crestani, B. (2011) · European Respiratory Review · doi:10.1183/09059180.00001311 · Cited by 301
Display technologies: Application for the discovery of drug and gene delivery agents☆
SERGEEVA, A., KOLONIN, M., MOLLDREM, J., PASQUALINI, R., & ARAP, W. (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.018 · Cited by 266
Diseases of Pulmonary Surfactant Homeostasis
Whitsett, J. A., Wert, S. E., & Weaver, T. E. (2015) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-012513-104644 · Cited by 256
Bain, C. C., & MacDonald, A. S. (2022) · Mucosal Immunology · doi:10.1038/s41385-021-00480-w · Cited by 255
Shimizu, Y., Matsuzaki, S., Dobashi, K., Yanagitani, N., Satoh, T., Koka, M., Yokoyama, A., Ohkubo, T., Ishii, Y., Kamiya, T., et al. (2011) · Respiratory Research · doi:10.1186/1465-9921-12-88 · Cited by 18
“Auto anti-granulocyte-macrophage colony-stimulating factor (anti-GM-CSF) antibody is involved in the development of the idiopathic (autoimmune) form of PAP [3].”
Metadata
- Authors
- Kitamura, T., Tanaka, N., Watanabe, J., Uchida, Kanegasaki, S., Yamada, Y., & Nakata, K.
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 1999-09-20
- Volume
- 190
- Issue
- 6
- Pages
- 875-880
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2116622733
- Cited by
- 563
- References
- 15
- FWCI
- 10.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.